Invitation: 14 May 2020 – The WHO Covid-19 Technology Pool: The solution to ensure...
On 14 May 2020, Health Action International, Knowledge Ecology International, Medicines Law & Policy, Pharmaceutical Accountability Foundation, and Wemos will convene a briefing entitled:...
The new EU compulsory licensing regime needs to allow the export of medicines
Guest author Olga Gurgula is a Senior Lecturer in Intellectual Property Law at Brunel Law School, Brunel University London.
A war-weary Ukraine critically depends on the support of...
Affordability, binding commitments to technology sharing, and transparency key in Pathogen Access and Benefit...
We appreciate the opportunity to offer comments on the draft PABS annex text .
Some preliminary comments:
Affordability of Access: The current draft mentions "providing access...
2018 Round-up of Noteworthy Medicines Law and Policy Events
We are reaching the end of 2018: Time for our end-of-the-year roundup of some significant developments in medicines law and policy.
January
The Chilean parliament started...
We need a Global Vaccines Taskforce, not just a British or European one
The European Commission has been heavily criticised for its performance over Covid-19 vaccine supply to European Union Member States. Despite the urgency of the...
US Authorisation of Non-Voluntary Use of Patents frequently used for health technologies
During the Covid-19 pandemic, the United States prioritised the rapid development of products needed to combat the health crisis. Rapid product development was pursued...
Corbyn’s Compulsory Licenses. Will they work?
On 24 September, Jeremy Corbyn, leader of the UK Labour party, announced a series of measures to bring medicines pricing in check and to...
A second Covid-19 treatment will now be made available through the Medicines Patent Pool
The Medicines Patent Pool, a United Nations-backed public health organisation, today announced its second Covid-related voluntary licence agreement. The agreement will enable low-cost production...
The world needs a signal that multilateralism works: ML&P opening statement to the INB13,...
Thank you for the opportunity to make a brief statement.
The negotiations for the Pandemic Agreement enter the final phase. We hope and wish for...
Watch the webinar on the WHO Covid-19 Technology Pool
On 14 May 2020, Medicines Law & Policy together with Health Action International, WEMOS, The Foundation for Pharmaceutical Accountability and Knowledge Ecology International held...